Actively Recruiting

Age: 1Day - 18Years
All Genders
ID04709432

Extracorporeal Membrane Oxygenation (ECMO) Treatment of Children in Mainland China in the Past 10 Years

Led by Children's Hospital of Fudan University · Updated on 2026-03-16

500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the use of extracorporeal membrane oxygenation (ECMO) treatment in children across mainland China over the past 10 years. ECMO is a type of life support that helps the lungs and sometimes the heart when they are critically ill. This observational, cross-sectional study aims to understand how ECMO treatment has developed and been applied in critically ill children in China. The study collects information through questionnaires from hospitals that have provided ECMO support to children in the last decade. Data gathered include hospital details, ECMO equipment used, causes of illness, treatment plans, and ECMO modes. The study focuses on children who received ECMO treatment during this period. Participants' survival rates from admission to discharge (about 10 days) will be measured as the primary outcome. Secondary outcomes include the duration of ECMO support and the cost of treatment. This study involves reviewing past cases and gathering data without administering any new treatment, with the goal of better understanding ECMO's role in pediatric critical care in China.

CONDITIONS

Brief Title

ECMO Treatment of Children in China in the Past 10 Years

Who Can Participate

Age: 1Day - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age of 1 day to 18 years old
  • Children supported by ECMO in mainland China in the past 10 years
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Observational Period

Duration - Approximately 10 days per participant (from admission to discharge)

Participants who underwent ECMO treatment in the past 10 years are observed through collected data on treatment details and outcomes.

Data collection via questionnaires; no additional visits required

Trial Site Locations

Total: 1 location

1

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

Actively Recruiting

Loading map...

Research Team

Y

YING JIAYUN

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Multi-country, Two-arm, Open-label, Superiority, Randomise...

Infectious Disease

Actively Recruiting

2 locations

ARDS in Children and ECMO Initiation Strategies Impact on Ne...

Acute Respiratory Distress Syndrome

Actively Recruiting

99 locations

Closed-loop Medtronic 780G System in Youth With Type 1 Diabe...

Type 1 Diabetes

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here